The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*
Abstract
To determine whether hyperinsulinemia can directly reduce serum sex hormone-binding globulin (SHBG) levels in obese women with the polycystic ovary syndrome, six obese women with this disorder were studied. Before study, ovarian steroid production was suppressed in each woman by the administration of 7.5 mg of a long-acting GnRH agonist, leuprolide depot, im, on days -56, -28, and 0. This resulted in substantial reductions in serum concentrations of testosterone (from 1.72 +/- 0.29 nmol/L on day -56 to 0.32 +/- 0.09 nmol/L on day 0), non-SHBG-bound testosterone (from 104 +/- 16 pmol/L on day -56 to 19 +/- 5 pmol/L on day 0), androstenedione (from 7.25 +/- 1.65 nmol/L on day -56 to 2.78 +/- 0.94 nmol/L on day 0), estrone (from 371 +/- 71 pmol/L on day -56 to 156 +/- 29 pmol/L on day 0), estradiol (from 235 +/- 26 pmol/L on day -56 to 90 +/- 24 pmol/L on day 0), and progesterone (from 0.28 +/- 0.12 nmol/L on day -56 to 0.08 +/- 0.02 nmol/L on day 0). Serum SHBG levels, however, did not change (18.8 +/- 2.8 nmol/L on day -56 vs. 17.8 +/- 2.6 nmol/L on day 0). While continuing leuprolide treatment, the women were administered oral diazoxide (300 mg/day) for 10 days to suppress serum insulin levels. Diazoxide treatment resulted in suppressed insulin release during a 100-g oral glucose tolerance test (insulin area under the curve, 262 +/- 55 nmol/min.L on day 0 vs. 102 +/- 33 nmol/min.L on day 10; P less than 0.05) and deterioration of glucose tolerance. Serum testosterone, androstenedione, estrone, estradiol, and progesterone levels did not change during combined diazoxide and leuprolide treatment. In contrast, serum SHBG levels rose by 32% from 17.8 +/- 2.6 nmol/L on day 0 to 23.5 +/- 2.0 nmol/L on day 10 (P less than 0.003). Due primarily to the rise in serum SHBG levels, serum non-SHBG-bound testosterone levels fell by 43% from 19 +/- 5 pmol/L on day 0 to 11 +/- 4 pmol/L on day 10 (P = 0.05). These observations suggest that hyperinsulinemia directly reduces serum SHBG levels in obese women with the polycystic ovary syndrome independently of any effect on serum sex steroids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperinsulinaemia also plays an indirect role in hyperandrogenism by inhibiting hepatic sex hormone-binding globulin (SHBG) production, thus increasing free testosterone (Kiddy et al., 1989;Nestler et al., 1991).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Nestler et al., 1991
In the citing paper
“The result of IR is hyperinsulinemia, which has a central role in the pathogenesis of androgen excess in PCOS.”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [6]
Citations
Cites
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Self-citationBarbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Self-citationKIDDY, D. S., SHARP, P. S., WHITE, D. M., SCANLON, M. F., MASON, H. D., BRAY, C. S., POLSON, D. W., REED, M. J., & FRANKS, S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00857.x · Cited by 364
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease
DeVane, G. W., Czekala, N. M., Judd, H. L., & Yen, S. S. C. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90081-2 · Cited by 338
Cited by
Sorted by citations
Items 201–300 of 814
Baillargeon, J., Iuorno, M. J., Jakubowicz, D. J., Apridonidze, T., He, N., & Nestler, J. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030437 · Cited by 74
Self-citationKhorram, O., Helliwell, J. P., Katz, S., Bonpane, C. M., & Jaramillo, L. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.042 · Cited by 73
Baillargeon, J., Iuorno, M. J., Apridonidze, T., & Nestler, J. E. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0052 · Cited by 73
Self-citationRoles of LH and insulin resistance in lean and obese polycystic ovary syndrome
Grulet, H., Hécart, A. C., Delemer, B., Gross, A., Sulmont, V., Leuténegger, M., & Caron, J. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02144.x · Cited by 73
Practical Approach to Hyperandrogenism in Women
Sharma, A. R., & Welt, C. K. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.008 · Cited by 72
Metabolic complications of obesity
Pedersen, S. D. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.02.004 · Cited by 75
Korhonen, S., Hippeläinen, M., NISKANEN, L. K., Vanhala, M. J., & Saarikoski, S. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.109596 · Cited by 72
Önalan, G., Göktolga, Ü., Ceyhan, T., Bağış, T., Önalan, R., & Pabuçcu, R. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.05.010 · Cited by 71
Geller, D. H., Pacaud, D., Gordon, C. M., & Misra, M. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-9 · Cited by 72
Adcock, C., Perry, L. A., Lindsell, D. R., Taylor, A. M., Holly, J. M. P., Jones, J., & Dunger, D. B. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00307.x · Cited by 70
Vrbíková, J., Hill, M., Stárka, L., Cibula, D., Bendlová, B., Vondra, K., Šulcová, J., & Šnajderová, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440619 · Cited by 71
Tosi, F., Di Sarra, D., Kaufman, J.-M., Bonin, C., Moretta, R., Bonora, E., Zanolin, E., & Moghetti, P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2786 · Cited by 70
Nokoff, N., Thurston, J. E., Hilkin, A. M., Pyle, L., Zeitler, P. S., Nadeau, K. J., Santoro, N. F., & Kelsey, M. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02747 · Cited by 77
Sex Hormone-Binding Globulin in Children and Adolescents
Aydın, B. K., & Winters, S. J. (2016) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.2764 · Cited by 70
Medical vs. surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome
Malkawi, H. Y., Qublan, H. S., & Hamaideh, A. H. (2003) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610310000100123 · Cited by 70
Inositol and human reproduction. From cellular metabolism to clinical use
Milewska, E. M., Czyzyk, A., Meczekalski, B., & Genazzani, A. D. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1188282 · Cited by 69
Tolino, A., Gambardella, V., Caccavale, C., D’Ettore, A., Giannotti, F., D’Antò, V., & De Falco, C. L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.06.043 · Cited by 69
Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach
Nautiyal, H., Imam, S. S., Alshehri, S., Ghoneim, M. M., Afzal, M., Alzarea, S. I., Güven, E., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Biomedicines · doi:10.3390/biomedicines10030540 · Cited by 80
Efficacy of omega-3 in the treatment of polycystic ovary syndrome
Öner, G., & Müderris, İ. İ. (2013) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2012.751365 · Cited by 68
Puberty and its disorders in the female
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00024-x · Cited by 67
Sowers, M. R., Derby, C. A., Jannausch, M. L., Torréns, J. I., & Pasternak, R. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030350 · Cited by 66
Legro, R. S., Brzyski, R. G., Diamond, M. P., Coutifaris, C., Schlaff, W. D., Alvero, R. J., Casson, P. R., Christman, G. M., Huang, H., Yan, Q., et al. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.08.056 · Cited by 64
MicroRNAs related to androgen metabolism and polycystic ovary syndrome
Sørensen, A. E., Udesen, P. B., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.008 · Cited by 65
Ivandíc, A., Prpić-Kriẑevac, I., Sučić, M., & Jurić, M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90186-x · Cited by 63
Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes
Stefan, N., Schick, F., & Häring, H.-U. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0910143 · Cited by 66
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Lucenteforte, E., Bosetti, C., Talamini, R., Montella, M., Zucchetto, A., Pelucchi, C., Franceschi, S., Negri, E., Levi, F., & Vecchia, C. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603933 · Cited by 65
Maternal whole grain intake and outcomes of in vitro fertilization
Gaskins, A. J., Chiu, Y., Williams, P. L., Keller, M. G., Toth, T. L., Hauser, R. B., & Chavarro, J. E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.02.015 · Cited by 65
Clinical implications of hyperinsulinaemia in women
Conway, G. S., & Jacobs, H. S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02419.x · Cited by 66
Polymorphisms in theSHBGGene Influence Serum SHBG Levels in Women with Polycystic Ovary Syndrome
Wickham, E. P., Ewens, K. G., Legro, R. S., Dunaif, A. E., Nestler, J. E., & Strauss, J. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1842 · Cited by 64
Self-citationXue, Y., Lv, J., Xu, P., Gu, L., Cao, J., Xu, L., Xue, K., & Li, Q. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26531 · Cited by 64
6 Current concepts of polycystic ovary syndrome
Rosenfield, R. L. (1997) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(97)80039-9 · Cited by 64
Glueck, C. J., Morrison, J. A., Daniels, S., Wang, P., & Stroop, D. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.01.018 · Cited by 63
Relationship of insulin secretory pulses to sex hormone-binding globulin in normal men
Peiris, A. N., Stagner, J. I., Plymate, S. R., Vogel, R. L., Heck, M., & Samols, E. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432769 · Cited by 62
Self-citationGenazzani, A. D., Lanzoni, C., Ricchieri, F., Baraldi, E., Casarosa, E., & Jasonni, V. M. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701214398 · Cited by 62
Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
Zhang, B., Wang, J., Shen, S., Liu, J., Sun, J., Gu, T., Ye, X., Zhu, D., & Bi, Y. (2018) · BioMed Research International · doi:10.1155/2018/6869705 · Cited by 62
Lifetime recreational exercise activity and risk of breast carcinoma in situ
Patel, A. V., Press, M. F., Meeske, K., Calle, E. E., & Bernstein, L. (2003) · Cancer · doi:10.1002/cncr.11768 · Cited by 61
Sex hormone—binding globulin and insulin resistance in African-American women
Sherif, K., Kushner, H., & Falkner, B. E. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90195-0 · Cited by 61
Screening and the prevention of gynecologic cancer: Endometrial cancer
Sonoda, Y., & Barakat, R. R. (2005) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2005.10.015 · Cited by 62
Lee, C. C., Kasa-Vubu, J. Z., & Supiano, M. A. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.018 · Cited by 60
Legro, R. S., Azziz, R., Ehrmann, D. A., Fereshetian, A. G., O’Keefe, M., & Ghazzi, M. N. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030044 · Cited by 60
Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
Song, M. J., & Choi, J. Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1053709 · Cited by 65
Reproductive risk factors across the female lifecourse and later metabolic health
Nichols, A. R., Chavarro, J. E., & Oken, E. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.002 · Cited by 66
Lima, M. F. P., Baracat, E. C., & Simões, M. D. J. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004000700007 · Cited by 59
Pertyńska−Marczewska, M., Diamanti‐Kandarakis, E., Zhang, J., & Merhi, Z. O. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.010 · Cited by 59
Estler, J. O. E. N., & Akubowicz, A. J. J. (2011) · Cited by 59
Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure?
Pirwany, I. R., & Tulandi, T. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00875-6 · Cited by 59
Romualdi, D., Giuliani, M., Cristello, F., Fulghesu, A. M., Selvaggi, L., Lanzone, A., & Guido, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.114 · Cited by 58
Polycystic ovary syndrome: a risk factor for cardiovascular disease?
Rajkhowa, M., Glass, M. R., Rutherford, A. J., Michelmore, K., & Balen, A. H. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11572.x · Cited by 58
Sucrose, High-Sugar Foods, and Risk of Endometrial Cancer—a Population-Based Cohort Study
Friberg, E., Wallin, A., & Wolk, A. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0402 · Cited by 58
PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic–pituitary–adrenal axis?
Doi, S. A. R., Towers, P. A., Scott, C., & Al-Shoumer, K. A. S. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.06.024 · Cited by 57
Sex hormone‐binding globulin in gestational diabetes
Bartha, J. L., Comino‐Delgado, R., Romero‐Carmona, R., & Gomez-Jaen, M. D. C. (2000) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079010839.x · Cited by 57
Andersson, B., Johannsson, G., Holm, G., Bengtsson, B., Sashegyi, A. I., Pavo, I. J., Mason, T. M., & Anderson, P. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8168 · Cited by 57
Lipoedema – myths and facts, Part 5
Bertsch, T., Erbacher, G., Corda, D., Damstra, R. J., van Duinen, K., Elwell, R., Smeenge, J., Faerber, G., Fetzer, S., Fink, J. M., et al. (2020) · Phlebologie · doi:10.1055/a-1012-7670 · Cited by 57
The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome
Katsiki, N., Georgiadou, E., & Hatzitolios, A. I. (2009) · Drugs · doi:10.2165/00003495-200969110-00001 · Cited by 56
The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS) – an extended critical analysis
Geisthövel, F., & Rabe, T. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60902-9 · Cited by 56
Maturana, M. A., & Spritzer, P. M. (2002) · Metabolism · doi:10.1053/meta.2002.29997 · Cited by 56
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., & Arslanian, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01958 · Cited by 55
Metformin: Past, Present, and Future
Chaudhary, S., & Kulkarni, A. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01539-1 · Cited by 64
Impact of diet and adiposity on circulating levels of sex hormone-binding globulin and androgens
Morisset, A., Blouin, K., & Tchernof, A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00083.x · Cited by 55
Plasma visfatin levels in normal weight women with polycystic ovary syndrome
Panidis, D., Farmakiotis, D., Rousso, D., Katsikis, I., Delkos, D., Piouka, A., Gerou, S., & Diamanti‐Kandarakis, E. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.05.014 · Cited by 55
Ciotta, L., Calogero, A. E., Farina, M., Leo, V. D., Marca, A. L., & Cianci, A. (2001) · Human Reproduction · doi:10.1093/humrep/16.10.2066 · Cited by 54
Deterioration of the Metabolic Risk Profile in Women
Pascot, A., Després, J., Lemieux, I., Alméras, N., Bergeron, J., Nadeau, A., Prud’homme, D., Tremblay, A., & Lemieux, S. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.902 · Cited by 56
Obesity and Polycystic Ovary Syndromea
Franks, S., Kiddy, D. S., Sharp, P. S., Singh, A., Reed, M. J., Seppälä, M. T., Koistinen, R. A., & Hamilton‐Fairley, D. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb37915.x · Cited by 55
Current perspectives of insulin resistance and polycystic ovary syndrome
Pauli, J. M., Raja-Khan, N. T., Wu, X., & Legro, R. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03460.x · Cited by 55
Period problems: disorders of menstruation in adolescents
Peacock, A., Alvi, N. S., & Mushtaq, T. (2010) · Archives of Disease in Childhood · doi:10.1136/adc.2009.160853 · Cited by 54
Rondanelli, M., Riva, A., Petrangolini, G., Allegrini, P., Giacosa, A., Fazia, T., Bernardinelli, L., Gasparri, C., Peroni, G., & Perna, S. (2021) · Nutrients · doi:10.3390/nu13103665 · Cited by 56
Koiou, E., Τζιόμαλος, Κ., Dinas, K. D., Katsikis, I., Kalaitzakis, E., Delkos, D., Kandaraki, E., & Panidis, D. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-330 · Cited by 53
Influences of weight, body fat patterning and nutrition on the management of PCOS
Lefebvre, P., Bringer, J., Renard, É., Boulet, F., Clouet, S., & Jaffiol, C. (1997) · Human Reproduction · doi:10.1093/humrep/12.suppl_1.72 · Cited by 57
Differentiating Polycystic Ovary Syndrome from Adrenal Disorders
Yeşiladalı, M., Yazici, M. G. K., Attar, E., & Keleştimur, F. (2022) · Diagnostics · doi:10.3390/diagnostics12092045 · Cited by 56
Kajaia, N., Binder, H., Dittrich, R., Oppelt, P. G., Flor, B. D. A., Cupisti, S., Beckmann, M. W., & Mueller, A. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0203 · Cited by 52
Hyperinsulinism and Its Interaction With Hyperandrogenism in Polycystic Ovary Syndrome
Sozen, I., & Arici, A. M. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200005000-00026 · Cited by 52
Loverro, G., Vicino, M., Lorusso, F. P., Vimercati, A., Greco, P., & Selvaggi, L. E. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.2.142.149 · Cited by 52
Guido, M. (2004) · Human Reproduction · doi:10.1093/humrep/deh145 · Cited by 52
Alizadeh, M., Karandish, M., Jafarabadi, M. A., Heidari, L., Nikbakht, R., Babaahmadi‐Rezaei, H., & Mousavi, R. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00586-9 · Cited by 51
Androgens in Polycystic Ovary Syndrome: The Role of Exercise and Diet
Giallauria, F., Palomba, S., Vigorito, C., Tafuri, M. G., Colao, A., Lombardi, G., & Orio, F. (2009) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1225258 · Cited by 52
Economou, F., Xyrafis, X., Livadas, S., Androulakis, I. I., Argyrakopoulou, G., Christakou, C. D., Kandaraki, E., Palioura, E., & Diamanti‐Kandarakis, E. (2009) · HORMONES · doi:10.14310/horm.2002.1236 · Cited by 51
Bone mineral density in women with polycystic ovary syndrome
Katulski, K., Sławek-Szmyt, S., Czyzyk, A., Podfigurna-Stopa, A., Paczkowska, K., Ignaszak, N., Podkowa, N., & Męczekalski, B. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0175-5 · Cited by 53
Matsuzaki, T., Tungalagsuvd, A., Iwasa, T., Munkhzaya, M., Yanagihara, R., Tokui, T., Yano, K., Mayila, Y., Kato, T., Kuwahara, A., et al. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0282 · Cited by 52
Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. I
Sperling, L. C., & Heimer, W. L. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70092-8 · Cited by 51
Hyperinsulinism and sex hormones in young adult African Americans
Falkner, B. E., Sherif, K., Sumner, A. E., & Kushner, H. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90018-5 · Cited by 50
Prediction of Insulin Sensitivity in Nonobese Women with Polycystic Ovary Syndrome
Cibula, D., Škrha, J., Hill, M., Fanta, M., Haaková, L., Vrbíková, J., & Zivny, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020586 · Cited by 50
Beer, N., Jakubowicz, D. J., Beer, R. M., & Nestler, J. E. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962276 · Cited by 50
Self-citationAtherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism
Castelo‐Branco, C., Steinvarcel, F., Osorio, A., Ros, C., & Balasch, J. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.481025 · Cited by 49
Charitidou, C., Farmakiotis, D., Zournatzi, V., Pidonia, I., Pegiou, T., Karamanis, N., Hatzistilianou, M. N., Katsikis, I., & Panidis, D. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.002 · Cited by 49
Polycystic ovary syndrome: Current and future treatment paradigms
Legro, R. S. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70240-6 · Cited by 47
Vosnakis, C., Georgopoulos, N. A., Rousso, D., Mavromatidis, G., Katsikis, I., Roupas, N. D., Mamali, I., & Panidis, D. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.736557 · Cited by 48
Hassa, H., Tanir, H. M., & Yıldız, Z. (2006) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-006-0173-8 · Cited by 48
Polycystic Ovary Syndrome and the Metabolic Syndrome
Sharpless, J. L. (2003) · Clinical Diabetes · doi:10.2337/diaclin.21.4.154 · Cited by 49
Coffee drinking and risk of endometrial cancer—A population‐based cohort study
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24543 · Cited by 48
Polycystic ovary syndrome: an endocrine and metabolic disease
Scarpitta, A. M., & Sinagra, D. (2000) · Gynecological Endocrinology · doi:10.3109/09513590009167709 · Cited by 47
Desmeules, A. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.018 · Cited by 47
Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review
Carvalho, L. M. L., dos Reis, F. M., Cândido, A. L., Nunes, F. F. C., Ferreira, C. N., & Gomes, K. B. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0026 · Cited by 48
Malkawi, H. Y., & Qublan, H. S. (2002) · Saudi Medical Journal · doi:10.15537/1658-3175.1726 · Cited by 46
Jakubowicz, D. J., Beer, N., Beer, R. M., & Nestler, J. E. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593454 · Cited by 46
Self-citationPanidis, D., Farmakiotis, D., Rousso, D., Katsikis, I., Kourtis, A., & Diamanti‐Kandarakis, E. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.02.017 · Cited by 45
Panidis, D., Farmakiotis, D., Koliakos, G., Rousso, D., Kourtis, A., Katsikis, I., Asteriadis, C., Karayannis, V., & Diamanti‐Kandarakis, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei055 · Cited by 45
Cree‐Green, M., Newcomer, B. R., Coe, G. V., Newnes, L., Baumgartner, A., Brown, M. S., Pyle, L., Reusch, J. E. B., & Nadeau, K. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00619.2014 · Cited by 45
Original Research Communications
Barbe, P., Bennet, A., Stebenet, M., Perret, B., & Louvet, J. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.3.319 · Cited by 44
Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43
Metadata
- Authors
- NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G.
- Affiliations
- Madigan Army Medical Center (US)
- ORCID
- PLYMATE, STEPHEN R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1991-01
- Volume
- 72
- Issue
- 1
- Pages
- 83-89
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2008509267
- Cited by
- 815
- References
- 38
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 25 · 2023: 25 · 2022: 28 · 2021: 38 · 2020: 27 · 2019: 25 · 2018: 18 · 2017: 25 · 2016: 25 · 2015: 30 · 2014: 22 · 2013: 27 · 2012: 18
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-18904)
- National Center for Research Resources (RR 00065, M01RR000065)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hyperinsulinemia, sex hormone-binding globulin, polycystic ovary syndrome, obesity, insulin resistance, diazoxide, leuprolide, GnRH agonist, testosterone, androstenedione, estradiol, estrone, glucose tolerance, insulin secretion, ovarian steroidogenesis, glucose-insulin interaction, insulin sensitivity index, insulin resistance index
- MeSH terms
- Adult, Androstenedione, Diazoxide, Estradiol, Estrone, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Gonadotropin-Releasing Hormone, Obesity, Polycystic Ovary Syndrome, Progesterone, Sex Hormone-Binding Globulin, Testosterone, Androstane-3,17-diol, Leuprolide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review